Jiangsu Hengrui Medicine Co., Ltd. (HKG:1276)

Jiangsu Hengrui Medicine Statistics

Total Valuation

HKG:1276 has a market cap or net worth of HKD 526.09 billion. The enterprise value is 487.21 billion.

Market Cap	526.09B
Enterprise Value	487.21B

Important Dates

The last earnings date was Thursday, August 21, 2025.

Earnings Date	Aug 21, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	258.20M
Shares Outstanding	n/a
Shares Change (YoY)	+0.62%
Shares Change (QoQ)	+3.54%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	3.69B

Valuation Ratios

The trailing PE ratio is 65.28 and the forward PE ratio is 50.70.

PE Ratio	65.28
Forward PE	50.70
PS Ratio	15.93
PB Ratio	8.13
P/TBV Ratio	8.41
P/FCF Ratio	74.80
P/OCF Ratio	55.25
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 53.56, with an EV/FCF ratio of 69.27.

EV / Earnings	60.45
EV / Sales	14.79
EV / EBITDA	53.56
EV / EBIT	59.35
EV / FCF	69.27

Financial Position

The company has a current ratio of 13.49, with a Debt / Equity ratio of 0.00.

Current Ratio	13.49
Quick Ratio	12.21
Debt / Equity	0.00
Debt / EBITDA	0.01
Debt / FCF	0.01
Interest Coverage	539.99

Financial Efficiency

Return on equity (ROE) is 14.41% and return on invested capital (ROIC) is 9.15%.

Return on Equity (ROE)	14.41%
Return on Assets (ROA)	8.45%
Return on Invested Capital (ROIC)	9.15%
Return on Capital Employed (ROCE)	12.64%
Revenue Per Employee	1.63M
Profits Per Employee	398,228
Employee Count	20,238
Asset Turnover	0.54
Inventory Turnover	1.72

Taxes

In the past 12 months, HKG:1276 has paid 1.21 billion in taxes.

Income Tax	1.21B
Effective Tax Rate	13.05%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	74.81
200-Day Moving Average	n/a
Relative Strength Index (RSI)	61.00
Average Volume (20 Days)	6,682,975

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:1276 had revenue of HKD 33.03 billion and earned 8.06 billion in profits. Earnings per share was 1.27.

Revenue	33.03B
Gross Profit	28.49B
Operating Income	8.23B
Pretax Income	9.28B
Net Income	8.06B
EBITDA	9.08B
EBIT	8.23B
Earnings Per Share (EPS)	1.27

Balance Sheet

The company has 39.70 billion in cash and 100.19 million in debt, giving a net cash position of 39.60 billion.

Cash & Cash Equivalents	39.70B
Total Debt	100.19M
Net Cash	39.60B
Net Cash Per Share	n/a
Equity (Book Value)	64.68B
Book Value Per Share	9.91
Working Capital	47.44B

Cash Flow

In the last 12 months, operating cash flow was 9.52 billion and capital expenditures -2.49 billion, giving a free cash flow of 7.03 billion.

Operating Cash Flow	9.52B
Capital Expenditures	-2.49B
Free Cash Flow	7.03B
FCF Per Share	n/a

Margins

Gross margin is 86.24%, with operating and profit margins of 24.91% and 24.40%.

Gross Margin	86.24%
Operating Margin	24.91%
Pretax Margin	28.09%
Profit Margin	24.40%
EBITDA Margin	27.48%
EBIT Margin	24.91%
FCF Margin	21.29%

Dividends & Yields

HKG:1276 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	34.66%
Buyback Yield	-0.62%
Shareholder Yield	n/a
Earnings Yield	1.53%
FCF Yield	1.34%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:1276 has an Altman Z-Score of 49.39 and a Piotroski F-Score of 6.

Altman Z-Score	49.39
Piotroski F-Score	6